Insider Trading: Aegerion Pharmaceuticals Inc (AEGR.O)

AEGR.O on Nasdaq

59.84USD
2:26pm EDT
Price Change (% chg)

$-0.27 (-0.45%)
Prev Close
$61.57
Open
$60.20
Day's High
$61.19
Day's Low
$59.67
Volume
224,811
Avg. Vol
630,342
52-wk High
$63.72
52-wk Low
$12.86

Search Stocks
All Insider Trades
Trading Date Name Title Type Shares Traded Price
21 Apr 2013

SUMERAY MARK

 Officer Sell 3,850 $40.40
21 Apr 2013

SUMERAY MARK

 Officer Sell 2,150 $41.36
21 Apr 2013

SUMERAY MARK

 Officer Buy 6,000 $13.01
31 Jan 2013

PERCEPTIVE ADVISORS L L C

 Beneficial Owner of More than 10% Class Buy 50,000 $27.79
22 Jan 2013

CARTER MARTHA J

 Officer Buy 500 $27.81
17 Jan 2013

PERCEPTIVE ADVISORS L L C

 Beneficial Owner of More than 10% Class Buy 50,000 $27.62
16 Jan 2013

PERCEPTIVE ADVISORS L L C

 Beneficial Owner of More than 10% Class Buy 25,000 $26.73
16 Jan 2013

PERCEPTIVE ADVISORS L L C

 Beneficial Owner of More than 10% Class Buy 25,000 $26.73
10 Jan 2013

PERCEPTIVE ADVISORS L L C

 Beneficial Owner of More than 10% Class Buy 125,000 $26.64
10 Jan 2013

PERCEPTIVE ADVISORS L L C

 Beneficial Owner of More than 10% Class Buy 200,000 $27.66
10 Jan 2013

PERCEPTIVE ADVISORS L L C

 Beneficial Owner of More than 10% Class Buy 150,000 $26.64
3 Dec 2012

PERCEPTIVE ADVISORS L L C

 Beneficial Owner of More than 10% Class Buy 20,000 $21.27
28 Nov 2012

PERCEPTIVE ADVISORS L L C

 Beneficial Owner of More than 10% Class Buy 30,000 $22.71
27 Nov 2012

PERCEPTIVE ADVISORS L L C

 Beneficial Owner of More than 10% Class Buy 70,000 $21.76
20 Nov 2012

PERCEPTIVE ADVISORS L L C

 Beneficial Owner of More than 10% Class Buy 20,000 $20.75
19 Nov 2012

PERCEPTIVE ADVISORS L L C

 Beneficial Owner of More than 10% Class Buy 20,000 $21.01
14 Nov 2012

PERCEPTIVE ADVISORS L L C

 Beneficial Owner of More than 10% Class Buy 10,000 $19.50
6 Nov 2012

PERCEPTIVE ADVISORS L L C

 Beneficial Owner of More than 10% Class Buy 30,000 $21.12
18 Oct 2012

PERCEPTIVE ADVISORS L L C

 Beneficial Owner of More than 10% Class Buy 247,500 $17.50
15 Oct 2012

ALTA BIOPHARMA PARTNERS III L P

 Beneficial Owner of More than 10% Class Sell 8,611 $18.67
15 Oct 2012

ALTA BIOPHARMA PARTNERS III L P

 Beneficial Owner of More than 10% Class Sell 3,160 $18.67
15 Oct 2012

ALTA BIOPHARMA PARTNERS III L P

 Beneficial Owner of More than 10% Class Sell 128,229 $18.67
14 Oct 2012

ALTA BIOPHARMA PARTNERS III L P

 Beneficial Owner of More than 10% Class Sell 3,736 $17.54
14 Oct 2012

ALTA BIOPHARMA PARTNERS III L P

 Beneficial Owner of More than 10% Class Sell 55,626 $17.54
14 Oct 2012

ALTA BIOPHARMA PARTNERS III L P

 Beneficial Owner of More than 10% Class Sell 1,371 $17.54
Previous Page 1 of 5  Next

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 148
Total Shares Held: 30,770,021
3 Mo. Net Change: 5,848,735
# New Positions: 44
# Closed Positions: 13
# Increased Positions: 109
# Reduced Positions: 45
# Net Buyers: 64

Officers & Directors

Name Age Since Current Position

David Scheer

 60 2005 Independent Chairman of the Board

Marc Beer

 48 2010 Chief Executive Officer, Director

Mark Fitzpatrick

 49 2011 Chief Financial Officer

Anne Cook

 50 2011 Senior Vice President, General Counsel, Secretary

Martha Carter

 59 2011 Chief Regulatory Officer and Senior Vice President

Mark Sumeray

 46 2011 Chief Medical Officer

Anne VanLent

 2013 Director

Sol Barer

 2011 Independent Director

Antonio Gotto

 76 2006 Independent Director

Sandford Smith

 65 2012 Independent Director

Paul Thomas

 56 2011 Independent Director

Amanda Murphy

 IR Contact Officer
Search Stocks